Drug Patent Reports now available on Amazon
DrugPatentWatch now offers single drug reports for purchase on Amazon. These reports provide valuable insights and information about specific drugs. […]
DrugPatentWatch now offers single drug reports for purchase on Amazon. These reports provide valuable insights and information about specific drugs. […]
A recent paper published in the journal “Intelligent Medicine” article discusses various aspects of using AI and machine learning in
Artificial Intelligence and Machine Learning in Drug Discovery and Development Read Post »
A recent study explores the landscape of authorized generics in the United States pharmaceutical market. Authorized generics are brand-name drugs
Prevalence and timing of authorized generics in the US market Read Post »
A recent update from Foley & Lardner attorney Courtenay C. Brinckerhoff discusses trends in Inter Partes Review (IPR) and Post Grant
Insights into Shifting Dynamics: Orange Book and Biologic PTAB Trends Read Post »
In a recent Insight article published by Global Competition Review, legal experts from Lowenstein Sandler LLP delve into the status
In the world of prescription drugs, brand-name manufacturers have employed various strategies to maintain revenue streams in the face of
A review article in the Journal of Pharmaceutical Sciences analyzes the trends in drug repurposing through the 505(b)(2) pathway, as
Here’s a summary of a new article that used DrugPatentWatch data: NIH Funding for Patents That Contribute to Market Exclusivity
While answering a question for a DrugPatentWatch user, the question arose of technologies the NIH has licensed. It turns out
Subscribe to our weekly newsletter below and never miss the latest product or an exclusive offer.